Cargando…

Can atrial natriuretic peptides measurement diagnose heart failure at different age groups?

Detalles Bibliográficos
Autor principal:	Golabchi, Allahyar
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications & Media Pvt Ltd 2012
Materias:	Letter to Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3523432/ https://www.ncbi.nlm.nih.gov/pubmed/23248669

Ejemplares similares

Smoking Paradox at Cardiac Rehabilitation
por: Allahyar, Golabchi
Publicado: (2012)

Which method has the most accurate measurement of daily salt intake?
por: Golabchi, Allahyar, et al.
Publicado: (2015)

Awareness of atrial fibrogenesis and natriuretic peptide release
por: Meijers, W. C. F. W., et al.
Publicado: (2017)

Significance of Atrial and Brain Natriuretic Peptide Measurements in Fetuses With Heart Failure
por: Miyoshi, Takekazu, et al.
Publicado: (2021)

Low voltage areas, atrial natriuretic peptides and fibrosis: Challenges and controversies
por: Floria, Mariana, et al.
Publicado: (2020)

Clinical Applications of Natriuretic Peptides in Heart Failure and Atrial Fibrillation
por: Baba, Masako, et al.
Publicado: (2019)

Assessment of Natriuretic Peptides: The Heart Should Be Evaluated as a Whole
por: Yalcinkaya, Emre, et al.
Publicado: (2014)

Role of natriuretic peptide receptor C signalling in obesity-induced heart failure with preserved ejection fraction with pulmonary hypertension
por: Eroume-A Egom, Emmanuel, et al.
Publicado: (2020)

Efficacy of exogenous atrial natriuretic peptide in patients with heart failure with preserved ejection fraction: deficiency of atrial natriuretic peptide and replacement therapy
por: Matsumoto, Shingo, et al.
Publicado: (2020)

Caveats in the interpretation of natriuretic peptide levels
por: Chao, Chia-Ter
Publicado: (2011)

Authors’ reply: role of natriuretic peptide receptor C signalling in obesity-induced heart failure with preserved ejection fraction with pulmonary hypertension
por: Agrawal, Vineet, et al.
Publicado: (2020)

Natriuretic Peptides in Chronic Heart Failure
por: Brunner-La Rocca, Hans-Peter, et al.
Publicado: (2019)

Atrial Natriuretic Peptides as a Bridge between Atrial Fibrillation, Heart Failure, and Amyloidosis of the Atria
por: Rahbar Kouibaran, Farzad, et al.
Publicado: (2023)

Brain natriuretic peptide among stroke patients
por: Saritas, Ayhan, et al.
Publicado: (2014)

Monitoring of heart failure: comparison of left atrial pressure with intrathoracic impedance and natriuretic peptide measurements in an experimental model of ovine heart failure
por: Rademaker, Miriam T., et al.
Publicado: (2010)

Takotsubo cardiomyopathy or broken heart syndrome: A review article
por: Golabchi, Allahyar, et al.
Publicado: (2011)

Diagnostic accuracy of left atrial remodelling and natriuretic peptide levels for preclinical heart failure
por: Tsai, Jui‐Peng, et al.
Publicado: (2019)

Plasma atrial natriuretic peptide and N-terminal pro B-type natriuretic peptide concentrations in dogs with right-sided congestive heart failure
por: KANNO, Nobuyuki, et al.
Publicado: (2015)

On the occasion of World Heart Day: Do we have an effective period of cardiac rehabilitation program in Iran?
por: Basati, Fatemeh, et al.
Publicado: (2016)

Comments to “Neutrophil-to-lymphocyte ratio compared to N-terminal pro-brain natriuretic peptide as a prognostic marker of adverse events in elderly patients with chronic heart failure”
por: Cosansu, Kahraman, et al.
Publicado: (2017)

B-type natriuretic peptide for the prediction of left ventricular remodelling
por: Bauters, Christophe, et al.
Publicado: (2014)

Natriuretic peptide and cardiac troponin levels in doxorubicin-induced cardiotoxicity
por: Gülgün, Mustafa, et al.
Publicado: (2016)

Potential and Limitations of Atrial Natriuretic Peptide as Biomarker in Pediatric Heart Failure—A Comparative Review
por: Gangnus, Tanja, et al.
Publicado: (2019)

Rosiglitazone treatment restores renal responsiveness to atrial natriuretic peptide in rats with congestive heart failure
por: Goltsman, Ilia, et al.
Publicado: (2019)

Interactions Between Atrial Fibrillation and Natriuretic Peptide in Predicting Heart Failure Hospitalization or Cardiovascular Death
por: Brady, Paul F., et al.
Publicado: (2022)

Neuroendocrine hormone status and diuretic response to atrial natriuretic peptide in patients with acute heart failure
por: Matsumoto, Shingo, et al.
Publicado: (2022)

Atrial natriuretic peptide stimulates autophagy/mitophagy and improves mitochondrial function in chronic heart failure
por: Raffa, Salvatore, et al.
Publicado: (2023)

Relationship of atrial fibrillation and N terminal pro brain natriuretic peptide in heart failure patients
por: Nasab Mehrabi, Entezar, et al.
Publicado: (2023)

LV Dyssynchrony Assessed With Phase Analysis on Gated Myocardial Perfusion SPECT Can Predict Response to CRT in Patients With End-Stage Heart Failure
por: Azizian, Nasrin, et al.
Publicado: (2014)

Natriuretic peptides (BNP and NT-proBNP): measurement and relevance in heart failure
por: Palazzuoli, A, et al.
Publicado: (2010)

N-terminal pro brain natriuretic peptide in coronary artery disease
por: Tin, Sim Sai, et al.
Publicado: (2015)

Brain Natriuretic Peptides in Screening of Syncope with Cardiac Origin; a Commentary
por: Feiz Disfani, Hamideh, et al.
Publicado: (2018)

A new algorithm of suspected stroke patient management with brain natriuretic peptide/N-terminal pro-brain natriuretic peptide point of care testing platform in the emergency department
por: He, Mingfeng, et al.
Publicado: (2017)

Can doubling the maintenance dose of clopidogrel prevent from early stent thrombosis after the primary percutaneous coronary intervention?
por: Roghani, Farshad, et al.
Publicado: (2011)

Congestive Heart Failure – Can the Nephrologist Help?
por: Drummond, Garfield A, et al.
Publicado: (2000)

Reply to: N-terminal pro brain natriuretic peptide in coronary artery disease
por: Radwan, Hanan, et al.
Publicado: (2015)

Associations of atrial natriuretic peptide with measures of insulin and adipose depots
por: Couch, Catharine A., et al.
Publicado: (2023)

Designer natriuretic peptides for heart failure: advanced in clinical development
por: Burnett, John
Publicado: (2011)

Modulating cGMP in heart failure by novel natriuretic peptides
por: Burnett, John C
Publicado: (2009)

Clinical Significance of B-type Natriuretic Peptide in Heart Failure
por: Yoo, Byung-Su
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_jp0utn1jrtm2dc4fplqhkumtjm